240 related articles for article (PubMed ID: 7867580)
1. N-terminal-truncated recombinant analogs of bovine placental lactogen: interaction with human and rat growth hormone receptors and insulin-like growth factor-I secretion mediated by somatogenic receptors in rat hepatocytes.
Vashdi-Elberg D; Staten NR; Sakal E; Krivi GG; Gertler A
Endocrinology; 1995 Mar; 136(3):1258-66. PubMed ID: 7867580
[TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis of recombinant bovine placental lactogen at lysine-73 leads to selective attenuation of its somatogenic activity.
Helman D; Staten NR; Byatt J; Grosclaude J; McKinnie RE; Djiane J; Gertler A
Endocrinology; 1997 Oct; 138(10):4069-80. PubMed ID: 9322914
[TBL] [Abstract][Full Text] [Related]
3. The growth hormone (GH)-binding protein cloned from human IM-9 lymphocytes modulates the down-regulation of GH receptors by 22- and 20-kilodalton human GH in IM-9 lymphocytes and the biological effects of the hormone in Nb2 lymphoma cells.
Hansen BS; Hjorth S; Welinder BS; Skriver L; De Meyts P
Endocrinology; 1993 Dec; 133(6):2809-17. PubMed ID: 8243308
[TBL] [Abstract][Full Text] [Related]
4. Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems.
Rowlinson SW; Waters MJ; Lewis UJ; Barnard R
Endocrinology; 1996 Jan; 137(1):90-5. PubMed ID: 8536647
[TBL] [Abstract][Full Text] [Related]
5. Selective modification of recombinant bovine placental lactogen by site-directed mutagenesis at its C terminus.
Vashdi-Elberg D; Staten NR; Sakal E; McKinnie RE; Djiane J; Krivi GG; Gertler A
J Biol Chem; 1996 Mar; 271(10):5558-64. PubMed ID: 8621415
[TBL] [Abstract][Full Text] [Related]
6. Site-directed mutations of human growth hormone that selectively modify its lactogenic activity and binding properties.
Binder L; Gertler A; Elberg G; Guy R; Vogel T
Mol Endocrinol; 1990 Jul; 4(7):1060-8. PubMed ID: 2178223
[TBL] [Abstract][Full Text] [Related]
7. Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities.
Towns R; Kostyo JL; Vogel T; Sakal E; Tchelet A; Maher R; Gertler A
Endocrinology; 1992 Mar; 130(3):1225-30. PubMed ID: 1537288
[TBL] [Abstract][Full Text] [Related]
8. Biological activity of bovine placental lactogen in 3T3-F442A preadipocytes is mediated through a somatogenic receptor.
Vashdi D; Elberg G; Sakal E; Gertler A
FEBS Lett; 1992 Jun; 305(2):101-4. PubMed ID: 1618336
[TBL] [Abstract][Full Text] [Related]
9. Ovine placental lactogen is a potent somatogen in the growth hormone (GH)-deficient rat: comparison of somatogenic activity with bovine GH.
Singh K; Ambler GR; Breier BH; Klempt M; Gluckman PD
Endocrinology; 1992 May; 130(5):2758-66. PubMed ID: 1374015
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human growth hormone-binding protein fails to enhance the in vivo bioactivity of human growth hormone in normal rats.
Tzanela M; Wagner C; Tannenbaum GS
Endocrinology; 1997 Dec; 138(12):5316-24. PubMed ID: 9389516
[TBL] [Abstract][Full Text] [Related]
11. The molecular basis for growth hormone-receptor interactions.
Wells JA; Cunningham BC; Fuh G; Lowman HB; Bass SH; Mulkerrin MG; Ultsch M; deVos AM
Recent Prog Horm Res; 1993; 48():253-75. PubMed ID: 8441850
[TBL] [Abstract][Full Text] [Related]
12. Preparation, purification, and determination of the biological activities of 12 N terminus-truncated recombinant analogues of bovine placental lactogen.
Gertler A; Hauser SD; Sakal E; Vashdi D; Staten N; Freeman JJ; Krivi GG
J Biol Chem; 1992 Jun; 267(18):12655-9. PubMed ID: 1618771
[TBL] [Abstract][Full Text] [Related]
13. Chimeric bovine-human growth hormone prepared by recombinant DNA technology: binding properties and biological activity.
Binder L; Vogel T; Hadary D; Elberg G; Gertler A
Mol Endocrinol; 1989 Jun; 3(6):923-30. PubMed ID: 2739655
[TBL] [Abstract][Full Text] [Related]
14. Novel recombinant analogues of bovine placental lactogen. G133K and G133R provide a tool to understand the difference between the action of prolactin and growth hormone receptors.
Helman D; Staten NR; Grosclaude J; Daniel N; Nespoulous C; Djiane J; Gertler A
J Biol Chem; 1998 Jun; 273(26):16067-74. PubMed ID: 9632658
[TBL] [Abstract][Full Text] [Related]
15. Analysis of growth hormone and lactogenic binding sites cross-linked to iodinated human growth hormone.
Hughes JP; Simpson JS; Friesen HG
Endocrinology; 1983 Jun; 112(6):1980-5. PubMed ID: 6303751
[TBL] [Abstract][Full Text] [Related]
16. Site-directed mutagenesis of hGH at the 54-74 loop selectively modifies its lactogenic receptor-mediated biological activity.
Sakal E; Tchelet A; Uchida E; Shimokawa S; Nishikawa S; Hayakawa T; Krivi GG; Gertler A
Mol Cell Endocrinol; 1993 Nov; 97(1-2):129-34. PubMed ID: 8143895
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the somatogenic activity of bovine placental lactogen with cell lines transfected with the bovine somatotropin receptor.
Warren WC; Byatt JC; Huynh M; Paik K; Pegg G; Staten NR
Life Sci; 1999; 65(25):2755-67. PubMed ID: 10622285
[TBL] [Abstract][Full Text] [Related]
18. Indication of different lactogen and somatogen binding sites in the human growth hormone molecule as probed with monoclonal antibodies.
Strasburger CJ; Binder L; Elberg G; Cohen-Chapnik N; Kohen F; Gertler A
Mol Cell Endocrinol; 1989 Nov; 67(1):55-62. PubMed ID: 2482210
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of body weight gain of the mature female rat by bovine GH and bovine placental lactogen.
Byatt JC; Staten NR; Schmuke JJ; Buonomo FC; Galosy SS; Curran DF; Krivi GG; Collier RJ
J Endocrinol; 1991 Jul; 130(1):11-9. PubMed ID: 1880472
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH) binding protein and GH interactions in vivo in the guinea pig.
Fairhall KM; Carmignac DF; Robinson IC
Endocrinology; 1992 Oct; 131(4):1963-9. PubMed ID: 1396340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
